Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genentech, Inc.
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meet criteria for the diagnosis of allergic asthma
Diagnosis of asthma ≥ 6 months
Currently treated with only intermittent short-acting inhaled β-adrenergic agonists
Body weight between 40-120 kg
Normal chest X-ray within 2 years of screening
You may not be if
Require daily controller medication for asthma
History of hypersensitivity to the study drug or to drugs with similar chemical structures or to any ingredients, including excipients of the study medication or drugs related to MILR1444A (e.g., monoclonal antibodies, polyclonal gamma globulin)
Documented medical history of anaphylaxis
Immunotherapy currently or within the past 3 months prior to screening
Lung disease other than mild allergic asthma
Previous treatment with other investigational drugs within 30 days or 5 half-lives prior to the screening visit, whichever is longer
Pregnant or lactating
Significant concurrent medical illness other than asthma
Clinically significant abnormality on ECG at the screening visit
Smoked in the previous 6 months or have a history of smoking more than 10 pack-years
History of helminthic infection
Clareo Health | A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
